Go Pro
NYSEARCA:IDNA

iShares Genomics Immunology and Healthcare ETF (IDNA) Price, Holdings, & News

iShares Genomics Immunology and Healthcare ETF logo
$39.77 -0.52 (-1.29%)
As of 09/4/2026 04:10 PM Eastern

About iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)

Advanced

Key Stats

Today's Range
$39.60
$40.15
50-Day Range
$32.03
$41.48
52-Week Range
$22.33
$41.49
Volume
54,759 shs
Average Volume
51,051 shs
Market Capitalization
$234.64 million
Assets Under Management
$262.30 million
Dividend Yield
0.70%
Net Expense Ratio
0.47%
Aggregate Rating
Moderate Buy

ETF Overview

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.

iShares Genomics Immunology and Healthcare ETF Expenses

TypeIDNATheme ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.47%0.57%0.57%0.50%0.53%
Other Expenses0.00%0.57%0.53%0.60%0.54%
Total Expense0.47%0.72%0.75%0.75%0.73%
Fee Waiver0.00%-0.72%-0.67%-0.78%-0.68%
Net Expense0.47%0.60%0.63%0.57%0.60%
Receive IDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Genomics Immunology and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IDNA ETF News Headlines

(IDNA) iShares Genomics Immunology and Healthcare ETF
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the largest mineral reserve in the country - enough gold for a new Fort Knox, enough copper to rebuild the U.S. electric grid 25 times over. The Trump administration has previously staked positions in MP Materials, Lithium America, Trilogy Metals, and USA Rare Earth - each time shares moved higher. A landmark policy decision expected before November 3 could reprice this stock from $2 to $20 or more within a year.tc pixel
IDNA: 3 Catalysts To Watch Closely
iShares Genomics Immunology & Healthcare ETF
See More Headlines

IDNA ETF - Frequently Asked Questions

iShares Genomics Immunology and Healthcare ETF's stock was trading at $26.19 on January 1st, 2026. Since then, IDNA shares have increased by 51.9% and is now trading at $39.77.

Shares of IDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Genomics Immunology and Healthcare ETF investors own include iShares Micro-Cap ETF (IWC), The RMR Group (RMR), Waste Connections (WCN), DiamondRock Hospitality (DRH), AUO (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM).

Fund Details

Issuer
iShares
Fund Name
iShares Genomics Immunology and Healthcare ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:IDNA
Inception Date
6/11/2019
Fund Manager
Jennifer Hsui, Greg Savage, Paul Whitehead
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
NYSE FactSet Global Genomics and Immuno Biopharma Index
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
63

Fund Statistics

Assets Under Management
$262.30 million
Average Daily Volume
$0.00
Discount/Premium
0.03%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
BlackRock Fund Advisors
Custodian
State Street Bank and Trust Company
Distributor
BlackRock Investments, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
Optionable
Options Volume
11
Put Options
0
Call Options
11
Short Interest
33,524 shs

Miscellaneous

Beta
0.95
Creation Unit
50,000
Creation Fee
$850.00
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Top 10 IDNA Holdings

IDNA Sector Exposure

IDNA Industry Exposure


This page (NYSEARCA:IDNA) was last updated on 9/6/2026 by MarketBeat.com Staff.
From Our Partners